- Home
- NIXX vs QNCX Comparison
NIXX vs QNCX Comparison
Compare NIXX & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIXX
- QNCX
- Stock Information
- Founded
- NIXX 2010
- QNCX 2012
- Country
- NIXX United States
- QNCX United States
- Employees
- NIXX N/A
- QNCX N/A
- Industry
- NIXX
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NIXX
- QNCX Health Care
- Exchange
- NIXX NYSE
- QNCX Nasdaq
- Market Cap
- NIXX 39.8M
- QNCX 47.7M
- IPO Year
- NIXX N/A
- QNCX 2019
- Fundamental
- Price
- NIXX $1.78
- QNCX $1.50
- Analyst Decision
- NIXX
- QNCX Strong Buy
- Analyst Count
- NIXX 0
- QNCX 5
- Target Price
- NIXX N/A
- QNCX $8.00
- AVG Volume (30 Days)
- NIXX 255.3K
- QNCX 303.0K
- Earning Date
- NIXX 08-13-2025
- QNCX 08-12-2025
- Dividend Yield
- NIXX N/A
- QNCX N/A
- EPS Growth
- NIXX N/A
- QNCX N/A
- EPS
- NIXX N/A
- QNCX N/A
- Revenue
- NIXX $1,786,387.00
- QNCX N/A
- Revenue This Year
- NIXX N/A
- QNCX N/A
- Revenue Next Year
- NIXX N/A
- QNCX N/A
- P/E Ratio
- NIXX N/A
- QNCX N/A
- Revenue Growth
- NIXX 54.16
- QNCX N/A
- 52 Week Low
- NIXX $1.35
- QNCX $0.51
- 52 Week High
- NIXX $8.50
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- NIXX N/A
- QNCX 65.33
- Support Level
- NIXX N/A
- QNCX $1.29
- Resistance Level
- NIXX N/A
- QNCX $1.62
- Average True Range (ATR)
- NIXX 0.00
- QNCX 0.11
- MACD
- NIXX 0.00
- QNCX 0.03
- Stochastic Oscillator
- NIXX 0.00
- QNCX 74.47
About NIXX NIXXY INC
Nixxy Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.Recently, the Company acquired the license from GoLogiq, Inc. (GoLogiq), to operate its fintech technology (the GOLQ Technology) and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products.. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.